FDA Inspection 1165379 - Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb - March 18, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb, with an inspection on March 18, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Juno Therapeutics Inc, a subsidiary of Bristol-Myers Squibb
Inspection Date: March 18, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 1cb15bd3-1666-4ed4-9c26-58a4519a63c5